echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The world's first 15-valent HPV vaccine clinical trial application was accepted by the State Food and Drug Administration

    The world's first 15-valent HPV vaccine clinical trial application was accepted by the State Food and Drug Administration

    • Last Update: 2022-01-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Info

    On December 15, the clinical trial application of the recombinant 15-valent human papillomavirus (HPV) vaccine (Escherichia coli) jointly developed by Beijing Kangleweishi and Liaoning Chengda Biotechnology Co.


    HPV infection can cause diseases of the human reproductive system


    In January 2019, Kangle Guardian and Chengda Biotechnology signed a cooperation agreement to jointly develop and restructure 15-price HPV (6/11/16/18/31/33/35/39/45/51/52/56/58/59/ Type 68) vaccine


    At present, a total of 4 HPV vaccines have been approved for marketing in China, namely Merck’s Jiadaxiu (4 price), Jiadaxiu 9 (9 price), GlaxoSmithKline’s Cirix (2 price) and Wantai Biotech’s Xin Canning (2 price)


    In terms of research products, Zerun Bio's bivalent HPV (type 16/18) vaccine is currently in the stage of applying for the market, and has obtained the priority review qualification of NMPA


    In addition to the clinical 15-valent HPV vaccine, the recombinant trivalent HPV (16/18/58) vaccine (E.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.